Title:
NOVEL KYNURENINASE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/085280
Kind Code:
A1
Abstract:
The present invention relates to a novel kynureninase and a use thereof for cancer treatment. The novel kynureninase demonstrates similar or higher catalytic activity and thermal stability compared to already known kynureninases, and is more effective in reversing T cell proliferation inhibition induced by L-kynurenine (L-KYN) in an ex vivo culture system. Therefore, the novel kynureninase can be used as a powerful therapeutic enzyme to overcome the immunosuppressive tumor microenvironment. Particularly, the novel kynureninase shows excellent tumor growth inhibition effects in tumor animal models and can be used as an effective agent for various cancer immunotherapies with high industrial applicability.
More Like This:
Inventors:
MARTIN STEINEGGER (KR)
SONG WOON JU (KR)
YANG JINSOL (KR)
CHO KYE SOO (KR)
LEE MYEONG SUP (KR)
EOM HYUNUK (KR)
HAN YOUNG-HYUN (KR)
SONG WOON JU (KR)
YANG JINSOL (KR)
CHO KYE SOO (KR)
LEE MYEONG SUP (KR)
EOM HYUNUK (KR)
HAN YOUNG-HYUN (KR)
Application Number:
PCT/KR2022/016093
Publication Date:
April 25, 2024
Filing Date:
October 20, 2022
Export Citation:
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
GALUX INC (KR)
ASAN FOUND (KR)
UNIV ULSAN FOUND IND COOP (KR)
GALUX INC (KR)
ASAN FOUND (KR)
UNIV ULSAN FOUND IND COOP (KR)
International Classes:
C12N9/14; A61K35/17; A61K38/46; A61K47/68; A61P35/00; C07K19/00; C12N5/078; C12N15/62; C12N15/88
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF: